Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q421369> ?p ?o }
Showing triples 1 to 72 of
72
with 100 triples per page.
- Q421369 subject Q22230916.
- Q421369 subject Q7310239.
- Q421369 subject Q8264664.
- Q421369 subject Q8419336.
- Q421369 subject Q8872471.
- Q421369 subject Q8873601.
- Q421369 subject Q9052323.
- Q421369 abstract "Maraviroc (brand-named Selzentry, or Celsentri outside the U.S.) is an antiretroviral drug in the CCR5 receptor antagonist class used in the treatment of HIV infection. It is also classed as an entry inhibitor. It also appeared to reduce graft-versus-host disease in patients treated with allogeneic bone marrow transplantation for leukemia, in a phase 1/2 study.".
- Q421369 atcPrefix "J05".
- Q421369 atcSuffix "AX09".
- Q421369 bioavailability "23.0".
- Q421369 casNumber "376348-65-1".
- Q421369 chEBI "63608".
- Q421369 drugbank "DB04835".
- Q421369 fdaUniiCode "MD6P741W8A".
- Q421369 iupacName "4,4-difluoro-N-{(1S)-3-[3-(3-isopropyl- 5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl}cyclohexanecarboxamide".
- Q421369 pubchem "3002977".
- Q421369 thumbnail Maraviroc.svg?width=300.
- Q421369 wikiPageExternalLink 6404477.stm.
- Q421369 wikiPageExternalLink cms1282749.aspx.
- Q421369 wikiPageExternalLink default.aspx.
- Q421369 wikiPageExternalLink 2007-04-24-2624448028_x.htm.
- Q421369 wikiPageWikiLink Q1142055.
- Q421369 wikiPageWikiLink Q1194520.
- Q421369 wikiPageWikiLink Q1345259.
- Q421369 wikiPageWikiLink Q1368197.
- Q421369 wikiPageWikiLink Q14865176.
- Q421369 wikiPageWikiLink Q14874282.
- Q421369 wikiPageWikiLink Q15787.
- Q421369 wikiPageWikiLink Q1773075.
- Q421369 wikiPageWikiLink Q182506.
- Q421369 wikiPageWikiLink Q184204.
- Q421369 wikiPageWikiLink Q204711.
- Q421369 wikiPageWikiLink Q206921.
- Q421369 wikiPageWikiLink Q22230916.
- Q421369 wikiPageWikiLink Q2528140.
- Q421369 wikiPageWikiLink Q26163.
- Q421369 wikiPageWikiLink Q269829.
- Q421369 wikiPageWikiLink Q29496.
- Q421369 wikiPageWikiLink Q30612.
- Q421369 wikiPageWikiLink Q3557001.
- Q421369 wikiPageWikiLink Q421866.
- Q421369 wikiPageWikiLink Q5009692.
- Q421369 wikiPageWikiLink Q5058846.
- Q421369 wikiPageWikiLink Q5629942.
- Q421369 wikiPageWikiLink Q632518.
- Q421369 wikiPageWikiLink Q7310239.
- Q421369 wikiPageWikiLink Q7844975.
- Q421369 wikiPageWikiLink Q8264664.
- Q421369 wikiPageWikiLink Q8419336.
- Q421369 wikiPageWikiLink Q845326.
- Q421369 wikiPageWikiLink Q8872471.
- Q421369 wikiPageWikiLink Q8873601.
- Q421369 wikiPageWikiLink Q8880.
- Q421369 wikiPageWikiLink Q9052323.
- Q421369 atcPrefix "J05".
- Q421369 atcSuffix "AX09".
- Q421369 bioavailability "23.0".
- Q421369 casNumber "376348".
- Q421369 chebi "63608".
- Q421369 drugbank "DB04835".
- Q421369 iupacName "44".
- Q421369 pubchem "3002977".
- Q421369 unii "MD6P741W8A".
- Q421369 type ChemicalSubstance.
- Q421369 type Drug.
- Q421369 type ChemicalObject.
- Q421369 type Thing.
- Q421369 type Q8386.
- Q421369 comment "Maraviroc (brand-named Selzentry, or Celsentri outside the U.S.) is an antiretroviral drug in the CCR5 receptor antagonist class used in the treatment of HIV infection. It is also classed as an entry inhibitor. It also appeared to reduce graft-versus-host disease in patients treated with allogeneic bone marrow transplantation for leukemia, in a phase 1/2 study.".
- Q421369 label "Maraviroc".
- Q421369 depiction Maraviroc.svg.